Back to today’s briefing

Story perspectives

IBM Shares Plunge 25% After Weak Q2, Probe Ongoing

7/21/2026

40 5 Full Breakdown

Summary

IBM Shares Plunge

IBM reported Q2 results on July 14, causing a 25% share drop that erased about $69 billion in market value.
IBM posted $17.2 billion in revenue and $2.93 per share earnings, both below expectations.
CEO Arvind Krishna said IBM missed large deals, blamed a 7% decline in its IBM Z mainframe business and slower software growth.
Bank of America cut its IBM price target to $280, prompting HSBC to downgrade the stock.

Summary

IBM Under Probe

A securities fraud probe is examining whether IBM executives misled about deal flow before July 14 guidance.
IBM said it will fully cooperate and noted the investigation is in its early phase.
The dividend yield stays above 3% while sustainability hinges on free-cash-flow data due July 22.
Analysts’ average target of $271 values IBM $58 below its current $213.40 price.
22 analysts rate IBM: 14 Buy or Strong Buy, seven Hold, one Strong Sell.

History

Historical Context

The 2001 collapse of Enron, which filed for Chapter 11 on Dec 2, 2001 and wiped about $74 billion of market value, spurred the Sarbanes-Oxley Act of 2002 to tighten audit oversight. Regulators now cite that precedent as they examine IBM’s $69 billion share drop and securities-fraud probe, warning of similar compliance and investor-confidence risks.

1 of 3

IBM Shares Plunge

IBM reported Q2 results on July 14, causing a 25% share drop that erased about $69 billion in market value.
IBM posted $17.2 billion in revenue and $2.93 per share earnings, both below expectations.
CEO Arvind Krishna said IBM missed large deals, blamed a 7% decline in its IBM Z mainframe business and slower software growth.
Bank of America cut its IBM price target to $280, prompting HSBC to downgrade the stock.

1 / 3